A less common case of anti-MDA5 and anti-Ro52 antibody-positive juvenile dermatomyositis complicated with macrophage activation syndrome

被引:0
|
作者
Zhang, Li [1 ]
Zhang, Haiqing [2 ]
Liu, Shanshan [2 ]
Zhang, Ning [2 ]
Wang, Yun [2 ,3 ]
机构
[1] Qingdao Univ, Sch Basic Med, Dept Immunol, Qingdao, Peoples R China
[2] Qingdao Women & Childrens Hosp, Clin Lab, Qingdao, Peoples R China
[3] Qingdao Women & Childrens Hosp, Clin Lab, Qingdao 266034, Shandong, Peoples R China
来源
CLINICAL CASE REPORTS | 2024年 / 12卷 / 03期
关键词
anti-MDA5; antibody; anti-Ro52; interstitial lung disease; juvenile dermatomyositis; macrophage activation syndrome;
D O I
10.1002/ccr3.8613
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis
    Zhou, Mengmeng
    Ye, Yan
    Yan, Ninghui
    Lian, Xinyue
    Bao, Chunde
    Guo, Qiang
    CLINICAL RHEUMATOLOGY, 2020, 39 (06) : 1919 - 1927
  • [32] An Adolescent Case of Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis With Interstitial Lung Disease Successfully Treated by Multitarget Therapy Avoiding Cyclophosphamide: A Case Report and Literature Review
    Yokoyama, Tadafumi
    Inoue, Natsumi
    Sakumura, Naoto
    Tasaki, Yuko
    Wada, Taizo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [33] Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease
    Xu, Antao
    Ye, Yan
    Fu, Qiong
    Lian, Xinyue
    Chen, Sheng
    Guo, Qiang
    Lu, Liang-jing
    Dai, Min
    Lv, Xia
    Bao, Chunde
    RHEUMATOLOGY, 2021, 60 (07) : 3343 - 3351
  • [34] Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom
    Hattori, Yuki
    Matsuyama, Kanako
    Takahashi, Tomoko
    Shu, En
    Kanoh, Hiroyuki
    Seishima, Mariko
    CASE REPORTS IN DERMATOLOGY, 2018, 10 (02): : 110 - 114
  • [35] Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease
    Kaenmuang, Punchalee
    Navasakulpong, Asma
    RESPIROLOGY CASE REPORTS, 2021, 9 (01):
  • [36] Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis
    Abe, Yoshiyuki
    Matsushita, Masakazu
    Tada, Kurisu
    Yamaji, Ken
    Takasaki, Yoshinari
    Tamura, Naoto
    RHEUMATOLOGY, 2017, 56 (09) : 1492 - 1497
  • [37] The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients
    Ono, Nobuyuki
    Kai, Keita
    Maruyama, Akihito
    Sakai, Mariko
    Sadanaga, Yuri
    Koarada, Shuichi
    Inoue, Takuya
    Tada, Yoshifumi
    RHEUMATOLOGY, 2019, 58 (05) : 786 - 791
  • [38] Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease
    Gao, Yujuan
    Zhao, Qi
    Xie, Miaomiao
    Yan, Xin
    Li, Yan
    Zhang, Xin
    Wu, Hongyan
    Dai, Jinghong
    Cao, Min
    Cai, Hourong
    CYTOKINE, 2020, 135
  • [39] Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis A case report
    Endo, Yushiro
    Koga, Tomohiro
    Suzuki, Takahisa
    Hara, Kazusato
    Ishida, Midori
    Fujita, Yuya
    Tsuji, Sosuke
    Takatani, Ayuko
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Igawa, Takashi
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Kuwana, Masataka
    Kawakami, Atsushi
    MEDICINE, 2018, 97 (15)
  • [40] A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/ RO52 Antibodies, Combined with Necrotic Skin Ulcers
    Sun, Tian
    Hu, Zhong Hao
    He, Jin Shi
    Chen, Yu Chi
    Gao, Yong Xiang
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2024, 17 : 9 - 15